If you are a member of the media and have questions about Bayer in Canada, please contact Marija Mandic, Director of Communications, at email@example.com, or 416-240-5376, or Emily Hanft, Senior Business Communications Partner, at firstname.lastname@example.org, or 416-240-5466.
October 1, 2014Bayer closes acquisition of consumer care business of Merck & Co., Inc. for USD 14.2 billion
July 15, 2014Bayer’s New CONTOUR® NEXT LINK Blood Glucose Meter Now Available in Canada
July 7, 2014Nexavar® (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
June 17, 2014Bayer introduces JAYDESS®, a simple and safe alternative to the ‘Pill’
May 12, 2014Bayer’s Grants4Apps Initiative Looking for Canada’s Most Innovative Digital Healthcare Startups
May 2, 2014Young and Employable: Bayer Among the Best Places to Work
April 28, 2014Positive Results from Phase III DECISION Study of Sorafenib in RAI-Refractory Differentiated Thyroid Cancer Published in...
April 24, 2014Québec First Province to List Adempas® for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
April 24, 2014Quebecers suffering from wet Age-Related Macular Degeneration first with government coverage
April 22, 2014Two Green Thumbs Up for Bayer! Bayer named one of Canada’s Greenest Employers for the sixth consecutive year
April 17, 2014When Living With Hemophilia, It’s All About Attitude
March 10, 2014Adempas® now approved for second rare heart and lung disease, offering a new treatment option to improve patient care
February 26, 2014No Need to Fret, Ferret Friends! Advantage Multi® 9 is the First and Only Approved Therapy to Prevent Heartworm Disease...
February 5, 2014New Study: 4 in 10 Canadians Admit They Or A Partner Have Had A ‘Pregnancy Scare’
January 13, 2014Bayer HealthCare Announces Baycox® 5% (toltrazuril) Oral Suspension Approved for Sheep in Canada
December 18, 2013Bayer HealthCare to Join Not-For-Profit Structural Genomics Consortium to Accelerate Research in Epigenetics
November 27, 2013Bayer Is in Seventh Heaven!
November 14, 2013Real-World Data Confirm Clinical Value of Bayer’s Novel Oral Anticoagulant Xarelto in Protecting Patients Against Blood Clots
November 12, 2013Bayer receives approval for Eylea® as new drug to treat wet Age-Related Macular Degeneration Patients in Canada
October 21, 2013Bayer Comes Out on Top Once Again!